Transcatheter heart valves technologies

Successful management of acute left main coronary occlusion following transcatheter aortic valve implantation: a case report

Published on 17/10/2024 | Goranov Georgi 1 et al. | Journal of Medical Case Reports 2024; 18(1): 477 | 8 minute read

Abstract Background Transcatheter aortic valve implantation is an established, highly effective procedure in selected patients with severe degenerative aortic valve

Transcatheter heart valves technologies

Impact of prior hospitalization for heart failure on clinical outcomes of patients after transcatheter aortic valve implantation with new‐generation devices: Insights from the LAPLACE‐TAVI registry

Published on 17/10/2024 | Motoki FukutomiMD et al. | Catheterization and Cardiovascular Interventions 2024; AOP: 10.1002/ccd.31261 | 18 minute read

Abstract Background A history of hospitalization for heart failure (HHF) before transcatheter aortic valve implantation (TAVI) or surgical aortic valve

Transcatheter heart valves technologies

Recovery rate from conduction disorders in patients with permanent pacemaker implantation after transcatheter aortic valve implantation

Published on 03/10/2024 | Maria Yamamoto 1 et al. | Open Heart 2024; 11(2): e002867 | 14 minute read

Abstract Backgrounds Permanent pacemaker implantation (PPMI) is one of the greatest disadvantages of transcatheter aortic valve implantation (TAVI). To seek

$Elevated myocardial extracellular volume fraction as a new predictor of conduction defects after transcatheter aortic valve replacement$

Transcatheter heart valves technologies

Elevated myocardial extracellular volume fraction as a new predictor of conduction defects after transcatheter aortic valve replacement

Published on 03/10/2024 | Mehmet CilingirogluMD 1 et al. | Catheterization and Cardiovascular Interventions 2024; AOP: 10.1002/ccd.31252 | 4 minute read

Abstract Key points Transcatheter aortic valve replacement (TAVR) is now the standard of care for patients with severe symptomatic aortic

Transcatheter heart valves technologies

The impact of stroke and bleeding on mortality and quality of life during the first year after TAVI: A POPular TAVI subanalysis

Published on 19/09/2024 | Puck J. A.vanNuland 1 et al. | Catheterization and Cardiovascular Interventions 2024; AOP: 10.1002/ccd.31218 | 22 minute read

Abstract Background Bleeding and stroke are frequent complications after transcatheter aortic valve implantation (TAVI). The mortality risk associated with these

Transcatheter heart valves technologies

Difference in Cardiac Response after Transcatheter Aortic Valve Implantation according to Flow and Gradient Pattern

Published on 19/09/2024 | Hiroaki Yokoyama et al. | European heart journal cardiovascular Imaging 2024; aop: 10.1093/ehjci/jeae235 | 0 minute read

Transcatheter heart valves technologies

Hypercapnia during transcatheter aortic valve replacement under monitored anaesthesia care: a retrospective cohort study

Published on 05/09/2024 | Tzonghuei Chen 1 et al. | Open Heart 2024; 11(2): e002801 | 31 minute read

Abstract Background Acute intraoperative hypercapnia and respiratory acidosis, which can occur during monitored anaesthesia care (MAC), pose significant cardiopulmonary risks

Transcatheter heart valves technologies

CT‐derived simulations to predict outcomes in patients undergoing transcatheter aortic valve implantation with an ACURATE Neo2 valve the PRECISE‐TAVI cohort B trial

Published on 05/09/2024 | Thijmen W. HokkenMD 1 et al. | Catheterization and Cardiovascular Interventions 2024; AOP: 10.1002/ccd.31194 | 16 minute read

Abstract Background Paravalvular leakage (PVL) and conduction disorders that require permanent pacemaker implantation (PPI) remain clinically relevant challenges after transcatheter

Transcatheter heart valves technologies

Pre‐procedural nursing home length of stay and outcomes of transcatheter aortic valve replacement

Published on 15/08/2024 | Preston N.NicelyMD 1 et al. | Journal of the American Geriatrics Society 2024; AOP: 10.1111/jgs.19124 | 16 minute read

Abstract Background Older adults with severe aortic stenosis (AS) may receive care in a nursing home (NH) prior to undergoing

Transcatheter heart valves technologies

Two‐year follow‐up of transcatheter aortic valve replacement in low‐risk patients with symptomatic severe bicuspid aortic valve stenosis

Published on 15/08/2024 | Ilan MerdlerMD et al. | Catheterization and Cardiovascular Interventions 2024; AOP: 10.1002/ccd.31170 | 19 minute read

Abstract Background In 2019, the US Food and Drug Administration (FDA) approved transcatheter aortic valve replacement (TAVR) for low‐risk patients

This bibliographical database is provided by GNM Healthcare Group Companies USA, Inc. in full editorial independence.

The information published within the framework of this service may discuss or suggest certain therapies that have not been validated by the competent national authorities.
Service exclusively reserved for healthcare professionals.